Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

IGI Laboratories announces fifteenth ANDA submission

Monday, 2 Jun 2014 08:00am EDT 

IGI Laboratories Inc:Submits its second abbreviated new drug application (ANDA) in 2014 to the U.S. Food and Drug Administration (FDA). 

Company Quote

-1.2 -11.23%
1:36pm EST